Efficacy and Tolerability of Intravenous Levetiracetam in Children

Efficacy and Tolerability of Intravenous Levetiracetam in Children

Intractable epilepsy in children poses a serious medical challenge. Acute repetitive seizures and status epilepticus leads to frequent emergency room visits and hospital admissions. Permanent neurological damage can occur if there is delay in treatment. It has been shown that these children continue...

Full description

Bibliographic Details
Main Authors:	Jose eAceves, Owais eKhan, Diana eMungall, Ekokobe eFonkem, Chanin Clark Wright, Andrea eWenner, BATOOL F. KIRMANI
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2013-08-01
Series:	Frontiers in Neurology
Subjects:	Epilepsy Seizures Status Epilepticus Children intravenous levetiracetam Intractable epilepsy
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fneur.2013.00120/full

Similar Items

Clinical Pharmacology and Pharmacokinetics of Levetiracetam
by: Chanin Clark Wright, et al.
Published: (2013-12-01)

The role of Intravenous Levetiracetam in Treatment of Seizures in Brain Tumor Patients
by: Ekokobe eFonkem, et al.
Published: (2013-10-01)

Neurobehavioral Effects of Levetiracetam in Brain Tumor Related Epilepsy
by: Abigail eBernett, et al.
Published: (2013-07-01)

Role of Intravenous Levetiracetam in Seizure Prophylaxis of Severe Traumatic Brain Injury Patients
by: BATOOL F. KIRMANI, et al.
Published: (2013-11-01)

Role of Anticonvulsants in the Management of Posttraumatic Epilepsy
by: BATOOL F. KIRMANI, et al.
Published: (2016-03-01)

Role of Intravenous Levetiracetam in Acute Seizure Management
by: BATOOL F. KIRMANI
Published: (2014-06-01)

Management of Autoimmune Status Epilepticus
by: Batool F. Kirmani, et al.
Published: (2018-05-01)

Stuttering Priapism Associated with Levetiracetam
by: Mehmet Taylan PEKÖZ, et al.
Published: (2018-08-01)

A de novo heterozygous rare variant in SV2A causes epilepsy and levetiracetam-induced drug-resistant status epilepticus
by: Daniel G. Calame, et al.
Published: (2021-01-01)

Editorial: New Directions in the Management of Status Epilepticus
by: Batool F. Kirmani, et al.
Published: (2018-11-01)

A comparative assessment the efficacy of intravenous infusion of sodium valproate and phenytion in the treatment of status epilepticus
by: Ahmad Chitsaz, et al.
Published: (2013-01-01)

Effects of Levetiracetam Compared to Valproate on Cognitive Functions of Patients with Epilepsy
by: El Sabaa RM, et al.
Published: (2020-08-01)

Levetiracetam induced behavioral changes: a case report
by: R. Kamalraj, et al.
Published: (2018-12-01)

Relationship of levetiracetam and obsessive-compulsive disorder: a case report
by: Fikret Poyraz Çökmüş, et al.
Published: (2017-07-01)

Levetiracetam – epilepsy treatment, pharmacokinetics, mechanism of action, interaction and toxicity
by: Piotr Kozłowski, et al.
Published: (2015-04-01)

Levetiracetam – epilepsy treatment, pharmacokinetics, mechanism of action, interaction and toxicity
by: Piotr Kozłowski, et al.
Published: (2015-04-01)

Efficacy of Levetiracetam Monotherapy in Childhood Epilepsy
by: Müjgan ARSLAN, et al.
Published: (2017-04-01)

Clinical Application of Pharmacokinetics to Appraise Adherence to Levetiracetam in Portuguese Epileptic Patients
by: Rui Silva, et al.
Published: (2022-08-01)

Levetiracetam effectiveness as add-on therapy in Bulgarian patients with drug-resistant epilepsy
by: Ekaterina I. Viteva, et al.
Published: (2021-04-01)

Levetiracetam versus phenytoin in children with status epilepticus
by: Gowhar Wani, et al.
Published: (2019-01-01)

Levetiracetam Serum Concentrations in Pediatric Patients: Is There a Role in Clinical Decision Making?
by: Müjgan Arslan, et al.
Published: (2022-03-01)

A meta-analysis of randomized controlled trials on levetiracetam in the treatment of pediatric patients with epilepsy
by: Zhang LL, et al.
Published: (2018-03-01)

Should Levetiracetam or Imepitoin Be Used in Preference as Second-line Treatment in Pharmacoresistent Epileptic Cats?
by: Sophie Elizabeth Wyatt
Published: (2019-06-01)

A meta-analysis of levetiracetam for randomized placebo-controlled trials in patients with refractory epilepsy
by: Chen D, et al.
Published: (2019-04-01)

Levetiracetam and lamotrigine in old aged onset of epilepsy: a randomized double-blind clinical trial
by: Mahmood Motamedi, et al.
Published: (2013-12-01)

Hematological and Renal Effects of Levetiracetam Versus Lamotrigine in Children With Epilepsy: A Randomized Clinical Trial
by: Maryam Esteghamati, et al.
Published: (2022-07-01)

Blockade of TASK-1 Channel Improves the Efficacy of Levetiracetam in Chronically Epileptic Rats
by: Ji-Eun Kim, et al.
Published: (2022-03-01)

Evaluation of the Antioxidant Activity of Levetiracetam in a Temporal Lobe Epilepsy Model
by: Iván Ignacio-Mejía, et al.
Published: (2023-03-01)

Levetiracetam versus Oxcarbazepine as monotherapy in newly diagnosed focal epilepsy: A systematic review and meta‐analysis
by: Sanjeev Kharel, et al.
Published: (2022-11-01)

How about Levetiracetam in Glioblastoma? An Institutional Experience and Meta-Analysis
by: Ramazan Jabbarli, et al.
Published: (2021-07-01)

Levetiracetam‐induced aggression and acute behavioral changes: A case report and literature review
by: Jeff F Zhang, et al.
Published: (2022-03-01)

Intravenous levetiracetam versus phenobarbital in children with status epilepticus or acute repetitive seizures
by: Yun-Jeong Lee, et al.
Published: (2016-01-01)

Long-term levetiracetam monotherapy for partial epilepsy in adults
by: P. N. Vlasov, et al.
Published: (2014-01-01)

Behavioral Changes Under Levetiracetam Treatment in Dogs
by: Johannes Roland Erath, et al.
Published: (2020-04-01)

Comparison of levetiracetam as second-line drug with fosphenytoin in convulsive status epilepticus among children: A single center, open-label randomized controlled trial
by: S Anupama, et al.
Published: (2023-01-01)

Levetiracetam vs. Fosphenytoin for Second-Line Treatment of Status Epilepticus: Propensity Score Matching Analysis Using a Nationwide Inpatient Database
by: Kensuke Nakamura, et al.
Published: (2020-07-01)

Effects of Levetiracetam on the Serum C-Reactive Protein in Children With Epilepsy: A Meta-Analysis
by: You-Feng Zhou, et al.
Published: (2022-04-01)

A description of sodium valproate, lamotrigine and levetiracetam consumption in the Western Cape public sector
by: Nicole Keuler, et al.
Published: (2022-06-01)

Once-Daily Extended-Release Levetiracetam Improves Medication Compliance in Adolescent Epilepsy Patients
by: Seung Yeon Jung, et al.
Published: (2021-04-01)

Anti-seizures therapeutics in patients with epilepsy: an approach to levetiracetam – review
by: Barbara Rusinowska
Published: (2022-08-01)